The EHA Annual Congress provides a forum for presenting new data from clinical trials, basic and translational research and sharing ideas for hematological innovation as well as disseminating evidence-based knowledge of primary clinical relevance.
Hematologists and affiliated professionals attending the EHA Congress will be able to:
- Enhance their knowledge of evidence-based approaches on pathogenesis, diagnosis and treatment for hematologic diseases.
- Access the latest results on basic, clinical and translational research in hematology.
- Be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in hematology and its subspecialties.
- Communicate, collaborate and network with representatives of a large international audience – e.g. medical professionals, national hematology societies, patient groups, medical industry and the media.
These general goals for the Congress will be further elaborated with learning goals for the presentations of the Education Sessions.
Please find on the pages below the various parts of information about the congress program. We highly recommend you check also the What's New section with the introduction of new sessions and changes in the congress program.